ES2139647T3 - Composicion analgesica pulverizable y metodo de su empleo. - Google Patents

Composicion analgesica pulverizable y metodo de su empleo.

Info

Publication number
ES2139647T3
ES2139647T3 ES93900844T ES93900844T ES2139647T3 ES 2139647 T3 ES2139647 T3 ES 2139647T3 ES 93900844 T ES93900844 T ES 93900844T ES 93900844 T ES93900844 T ES 93900844T ES 2139647 T3 ES2139647 T3 ES 2139647T3
Authority
ES
Spain
Prior art keywords
spray composition
analgesic
analgesic spray
pulverizable
absorbed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900844T
Other languages
English (en)
Inventor
Joseph A Deihl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayor Pharmaceutical Laboratories Inc
Original Assignee
Mayor Pharmaceutical Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayor Pharmaceutical Laboratories Inc filed Critical Mayor Pharmaceutical Laboratories Inc
Application granted granted Critical
Publication of ES2139647T3 publication Critical patent/ES2139647T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA COMPOSICION ANALGESICA PULVERIZABLE QUE CONTIENE UN COMPUESTO ANALGESICO QUE ES ABSORBIDO EN LA SANGRE A TRAVES DE LA MUCOSA BUCAL Y UN PORTADOR LIQUIDO FARMACOLOGICAMENTE ACEPTABLE.
ES93900844T 1992-12-04 1992-12-04 Composicion analgesica pulverizable y metodo de su empleo. Expired - Lifetime ES2139647T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1992/010452 WO1994013280A1 (en) 1992-12-04 1992-12-04 Sprayable analgesic composition and method of use

Publications (1)

Publication Number Publication Date
ES2139647T3 true ES2139647T3 (es) 2000-02-16

Family

ID=22231593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900844T Expired - Lifetime ES2139647T3 (es) 1992-12-04 1992-12-04 Composicion analgesica pulverizable y metodo de su empleo.

Country Status (6)

Country Link
EP (1) EP0627915B1 (es)
JP (1) JPH07506839A (es)
AU (1) AU685741B2 (es)
DE (1) DE69230151T2 (es)
ES (1) ES2139647T3 (es)
WO (1) WO1994013280A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
ATE288255T1 (de) * 1996-04-12 2005-02-15 Novadel Pharma Inc Polares bukkales spray
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
AU4894697A (en) 1997-10-01 1999-04-23 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
AU770376B2 (en) * 1999-09-29 2004-02-19 Procter & Gamble Company, The Compositions having improved stability
EP2767163A1 (en) 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
CA2770683C (en) 2009-08-14 2018-09-04 Berg Biosystems, Llc Vitamin d3 and analogs thereof for treating alopecia
SG10201709894RA (en) * 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2975097A (en) * 1957-11-13 1961-03-14 Modern Lab Inc Topical analgesic composition
US3560625A (en) * 1967-02-20 1971-02-02 Colgate Palmolive Co Method of,and formulations for,introducing alkoxybenzamides into the systemic circulatory system
AU8533582A (en) * 1981-07-10 1984-01-12 Reckitt & Colman Products Limited Stable solutions of buprenorphine
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
JP2524709B2 (ja) * 1985-09-26 1996-08-14 塩野義製薬株式会社 鎮痛消炎作用増強剤
NL9000237A (nl) * 1990-01-31 1991-08-16 Re Novative Drugs For Dermatol Topicale farmaceutische composities voor de mondholte en vagina.
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels

Also Published As

Publication number Publication date
EP0627915A1 (en) 1994-12-14
JPH07506839A (ja) 1995-07-27
AU3237393A (en) 1994-07-04
AU685741B2 (en) 1998-01-29
EP0627915B1 (en) 1999-10-13
EP0627915A4 (en) 1996-02-07
DE69230151T2 (de) 2000-03-09
DE69230151D1 (de) 1999-11-18
WO1994013280A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
ES2139647T3 (es) Composicion analgesica pulverizable y metodo de su empleo.
ES2116447T3 (es) Una composicion farmaceutica que contiene un sistema definido de lipidos.
MX9405219A (es) Nueva formulacion farmaceutica.
DK0814784T3 (da) Anvendelse af NSAID'er til behandling af pladecellecarcinomer i mundhulen eller pars oralis pharyngis
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES2093747T3 (es) Composicion farmaceutica que contiene felbinac.
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
NO20011628D0 (no) Flytende tannrengjöringsgel
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
DK0768867T3 (da) Doseringsform til indgivelse af lægemiddel i væskeformig formulering
MX9306988A (es) Antagonistas de bradicinina y composicion farmaceutica que los comprende.
ES2192256T3 (es) Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
PL298890A1 (en) Sulfonylobenzyl substituted benzo- and pyridopyridones, method of obtaining sames and therapeutic agents containing them
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
CO4970816A1 (es) Combinaciones de estatina-eter carboxialquilico
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
MA22343A1 (fr) Compositions type massepain, contenant du psyllium
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
IT1193529B (it) Derivati adenosinici ad attivita' antinfiammatoria ed analgesica e composizioni terapeutiche che li contengono come principio attivo
ATE152354T1 (de) Protein c-haltige pharmazeutische präparation als mittel gegen entzündungen
DE3581006D1 (de) Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
FR2634825B1 (fr) Pompe a precompression pour la diffusion d'un liquide
IT1199064B (it) Procedimento ed apparecchio per l'applicazione di una composizione liquida o schiumosa ad un substrato

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 627915

Country of ref document: ES